Bicycle Therapeutics plc American Depositary Shares

BCYCNASDAQUSD
4.93 USD
0.36 (6.81%)AT CLOSE (11:59 AM EDT)
4.94
0.01 (0.10%)
POST MARKET (AS OF 07:26 PM EDT)
Post Market
AS OF 07:26 PM EDT
4.94
0.01 (0.10%)
🔴Market: CLOSED
Open?$5.32
High?$5.32
Low?$4.91
Prev. Close?$5.29
Volume?581.5K
Avg. Volume?528.2K
VWAP?$5.03
Rel. Volume?1.10x
Bid / Ask
Bid?$4.26 × 100
Ask?$5.67 × 100
Spread?$1.41
Midpoint?$4.97
Valuation & Ratios
Market Cap?368.8M
Shares Out?50.3M
P/E Ratio?N/A
P/B Ratio?0.60
EPS?-$3.14
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?11.98Strong
Quick Ratio?11.98Strong
Cash Ratio?11.02Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
92/100
P/E?
N/A
P/B?
0.60CHEAP
P/S?
5.08FAIR
P/FCF?
N/A
EV/EBITDA?
1.1CHEAP
EV/Sales?
-3.57CHEAP
Returns & Efficiency
ROE?
-35.9%WEAK
ROA?
-30.5%WEAK
Cash Flow & Enterprise
FCF?$-252025000
Enterprise Value?$-259359832
News
Profile
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.
Employees
288
Market Cap
371.5M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2019-05-23
Address
BLOCKS A & B, PORTWAY BUILDING
CAMBRIDGE, X0 CB21 6GS
Phone: 011441223261503